Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Immuron (IMRN) Debt Ratio (2016 - 2022)

Immuron's quarterly Debt Ratio came in at 14.05 in Q2 2022, up 36.45% year-on-year from 10.29 in Q2 2021, and up 36.45% quarter-over-quarter from 10.29 in Q2 2021.

Immuron has reported Debt Ratio for 6 years, with the latest figure at 14.05 in Q2 2022.

  • For the quarter ending Q2 2022, Debt Ratio rose 36.45% year-over-year to 14.05; the trailing twelve-month figure through Jun 2022 stood at 14.05 (up 36.45% YoY), and the FY2020 full-year result was 0.01, up 322.22% from the prior year.
  • Debt Ratio for Q2 2022 stood at 14.05, up from 10.29 in the prior quarter.
  • The five-year high for Debt Ratio was 14.05 in Q2 2022, with the low at 0.0 in Q2 2019.
  • Average Debt Ratio over 4 years is 6.09, with a median of 5.15 recorded in 2020.
  • Year-over-year, Debt Ratio surged 152756.32% in 2021 and soared 36.45% in 2022.
  • Tracing IMRN's Debt Ratio over 4 years: stood at 0.0 in 2019, then soared by 322.22% to 0.01 in 2020, then surged by 152756.32% to 10.29 in 2021, then jumped by 36.45% to 14.05 in 2022.
  • The last three Debt Ratio figures came in at 14.05 (Q2 2022), 10.29 (Q2 2021), and 0.01 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 14.05
Jun 30, 2021 10.29
Jun 30, 2020 0.01
Jun 30, 2019 0.00
Dec 31, 2017 0.04
Sep 28, 2017 0.03
Aug 31, 2017 0.03
Jun 30, 2017 0.02
Dec 31, 2016 0.13